Spry4 - sprouty RTK signaling antagonist 4

Predicted to enable protein kinase inhibitor activity. Predicted to be involved in animal organ development; negative regulation of signal transduction; and negative regulation of substrate adhesion-dependent cell spreading. Predicted to act upstream of or within cellular response to leukemia inhibitory factor. Predicted to be located in cytoplasm. Predicted to be active in cytosol. Human ortholog(s) of this gene implicated in hypogonadotropic hypogonadism 17 with or without anosmia. Orthologous to human SPRY4 (sprouty RTK signaling antagonist 4). [provided by Alliance of Genome Resources, Apr 2022]